Brain ischemia and reperfusion activate innate and adaptive immune system and break down of blood brain barrier.
CASE REPORT□患者杨XX,因走路偏斜2月,头晕1月,发现脑干占位1周余,于2012年12月20日入我院.□患者2月前无明诱因出现走路、骑单车向右偏斜,并渐出现言语语调顿挫不清,伴打嗝,呃逆.1月前(2011-11-17)出现头晕,无视物旋转,感自身站立不稳,伴有恶心、呕吐,重时卧床不起,不能睁眼.
中国脑卒中疾病负担令人堪忧Circulation·全球接近四成国家脑卒中负担超过缺血性心脏病·39％国家卒中死亡宰高于IHD死亡率,中国高居第二·32％国家卒中DALY损失宰高于IHD,中国高居第三上海社区人群的卒中高危风险●浦东南汇地区的健康档案的数据-2012年南汇大团镇的65岁以上人群开展卒中高危筛查13000例
Objective: Assess Butylphthalide soft capsules in preventing in-stent restenosis after stenting for moderate to severe atherosclerosis artery stenosis of intracranial and extracranial.
Objective: Aspirin is the most commonly used antiplatelet drug for primary and secondary prevention of stroke, myocardial infarction and cardiovascular death.
Objective: To analyze whether the clinical characteristics of single small subcortical infarction (SSSI) differ according to the lesion location in relation to the parent artery.
脑卒中是全球最重要的致死致残原因之一,缺血性脑卒中是其中最主要的发病类型.FDA批准静脉溶栓作为急性脑梗死超早期(4.5小时内)的治疗方式已有近20年的历史,它证据充分,但疗效有限,患者总体获益率不高.近年来,各种新兴的器械治疗明显提高了血管再通率,为扩大治疗时窗,提高治疗效果带来了新希望.
脑卒中—世界性问题脑卒中是由环境和遗传因素之间复杂相互作用而引发的一类疾病脑卒中发病机制临床和流行病学研究提示脑卒中有多种危险因素,如年龄、性别、肥胖、吸烟、高血压、糖屎病、血脂异常、同型半胱氨酸、载脂蛋白E、纤维蛋白原、C反应蛋白等辛中为多基因与环境因素相互复杂作用所致卒中存在单基因作用微弱、单个变异没有主效应、多种因素参与疾病进程、不完全外显或拟表型等特点
Objective: To investigate the imaging features on MRI of Enlarged perivascular spaces and their relation with other markers of cerebral small vessel disease.
Objective and Methods: Despite percutaneous transluminal angioplasty and stenting (PTAS) become an important treatment to control stroke occurrence, reoccurrence and mortality in patients with atheros